Journal profile · INFECTIOUS DISEASES
Infection and Chemotherapy
ISSN 2093-2340 · eISSN 2092-6448 · Jin Publishing & Printing Co. · Korea, Republic of
Infection and Chemotherapy: CAS Zone 4 · Medicine (2025 upgraded edition); diamond open access (no APC); no APC; median 65 days to acceptance (100 articles, last 24 months); 86 articles in 2025; indexed in ESCI and Scopus; the journal's website says it has moved to a new publisher.
The journal's website says it has moved to a new publisher: Infect Chemother provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in PubMed Central and KoreaMed. Source ↗Publisher website ·
Scope
Aims, scope and focus
Infection and Chemotherapy is published by Jin Publishing & Printing Co. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing and SARS-CoV-2 and COVID-19 Research, together about 17.5% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Infection & Chemotherapy (Infect Chemother) is an international, peer-reviewed, and open-access journal in English, which publishes the current research on issues posed by infectious diseases worldwide. Its regional focus is mainly Korea, but Infect Chemother welcomes submissions from researches all over the world. This journal, which is published quarterly (on the last day of March, June, September, and December) in both print and online (https://www.icjournal.org) versions, is the only official publication of the Korean Society of Infectious Diseases (http://www.ksid.or.kr/), Korean Society for Antimicrobial Therapy (formerly Korean Society for Chemotherapy) (http://www.ksat.or.kr/), the Korean Society for AIDS (http://www.kosaids.or.kr/) and Korean Society of Pediatric Infectious Diseases (https://www.kspid.or.kr/). It publishes review articles, original articles, brief communications, correspondences, case reports, editorials, and special articles covering an extensive range of clinical descriptions on infectious diseases, public health issues, microbiology including emerging resistance, parasitology and immunity to microbes, current and novel treatments, antimicrobial stewardship, and the promotion of optimal practices or guidelines for diagnoses and treatments representative of Korea and other countries or academic societies. Infect Chemother also covers the emerging and niche fields of infectious diseases such as multidrug resistant bacterial diseases, new drugs and vaccines, pandemic or emerging viral diseases, infectious diseases that are prevalent only in East Asia including Korea, and infectious diseases that have been forgotten. As the world continues to shrink as a result of globalization, it is necessary that appropriate communication is maintained among countries for timely sharing of information on infectious diseases. This is an important topic because such diseases tend to have unique biologic features according to the regions in which they develop, and these diseases can easily become nidus that may spread globally at any time. Based on these factors, the aim of this publication is to facilitate communication among societies and countries, enabling the worldwide sharing of information on infectious diseases. The scope of this journal is to link basic and clinical research in the field of infectious diseases, in reference to relevant evidence. The journal continuously attempts to publish current global and regional topics concerning infec
From the journal's Aims & Scope
Research area (LetPub): INFECTIOUS DISEASES
Editor-in-chief Wan BeomPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named South Korea 34, United States 6, Japan 2, Mainland China 1, Taiwan, China 1 (55 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology6.8%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology5.8%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.9%
- Respiratory viral infections researchMedicine4.7%
- COVID-19 Clinical Research StudiesMedicine4.6%
- Antimicrobial Resistance in StaphylococcusMedicine4.6%
- Antibiotic Use and ResistanceImmunology and Microbiology4.6%
- Streptococcal Infections and TreatmentsMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPubMedEmbaseCASPublisher website
Other: Google Scholar, Crossref, Crossref and DOI, CABI, KoreaMed Synapse, KoMCI
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 5.1LetPub ·
- SJR 2026-06
- 0.72LetPub ·
- SNIP 2026-06
- 0.83LetPub ·
- h-index
- 51OpenAlex ·
- i10-index
- 405OpenAlex ·
- 2-year mean citedness
- 2.58OpenAlex ·
- Self-citation rate
- 8.3%LetPub ·
- Share of gold OA articles
- 97.53%LetPub ·
Volume
- Articles per year
- 59LetPub ·
Articles by year OpenAlex count · 1,474 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 53 | 53 | 7 |
| 2025 | 86 | 86 | 141 |
| 2024 | 71 | 71 | 394 |
| 2023 | 65 | 65 | 420 |
| 2022 | 101 | 101 | 1,076 |
| 2021 | 92 | 92 | 1,275 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
65 daysMedian, submission to acceptance · P25–P75 32 days – 85 days
- Acceptance to online
- median 51 days (101 articles)
- Submission to online
- median 122 days
- Sample
- 100 articles with submission and acceptance dates (137 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 22 weeksLetPub ·
- Submission to publication (journal-reported)
- about 22 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC | |
| OpenAlex | USD 200 | — | — | |
| LetPub | USD 200 | No | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Page charges
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 400 words
- Keywords
- ≤ 5
- Manuscript length
- ≤ 5,500 words
- Reference style
- Vancouver
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted13, with length limits
- brief communicationARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…main text ≤ 1,500 words · abstract ≤ 100 words · figures and tables ≤ 3
- correspondenceARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…main text ≤ 500 words · figures and tables ≤ 1
- editorialARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…main text ≤ 1,200 words · figures and tables ≤ 1
- letterARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…Length not stated
- letters to the editorARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…Length not stated
- literature reviewARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…Length not stated
- meta-analysisARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…Length not stated
- obituaryInfect Chemother recognizes and honors our deceased members and their contributions to our society and to infectious diseases at large.Length not stated
- original articleARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…main text ≤ 5,500 words · abstract ≤ 400 words
- original research articleARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…Length not stated
- reviewARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…Length not stated
- review articleARTICLE DESCRIPTION ABSTRACT WORD LIMIT TABLES/FIGURES REFERENCES Review Article Review articles are usually solicited by the Editor-in-Chief. Authors should co…main text ≤ 6,500 words · abstract ≤ 200 words
- special articleSpecial articles are invited with an intention for special introduction of medical issues and any interesting information such as practice guidelines.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Plagiarism, Preprints
- Authorship Authorship Policy
No submission charge for all kinds of manuscripts submitted to the online system. Model summary
The Infect Chemother follows the recommendations for authorship by ICMJE (2025, http://www.icmje.org/icmje-recommendations.pdf) and Good Publication Practice Guidelines by KAMJE (2019, https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page=). The uniform requirements by the ICMJE recommend authorship as follows. Authorship credit should be based on 1) Substantial contributions …
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
The corresponding author of an article is asked to inform the Editor of the authors’ potential conflicts of interest possibly influencing their interpretation of data. A potential conflict of interest should be disclosed in the cover letter even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may be financial support or priva…
Source ↗Publisher website ·- Data availability DATA SHARING STATEMENT
Infect Chemother accepts the ICMJE Recommendations for data sharing statement policy (http://icmje.org/icmje-recommendations.pdf). All manuscripts reporting clinical trial results should submit a data sharing statement following the ICMJE guidelines from 1 July 2018. As one of the members of KAMJE, Infect Chemother agrees with the editorial, “Data Sharing statements for Clinical Trials: A Requirem…
Source ↗Publisher website ·- License & copyright COPYRIGHT AND CREATIVE COMMONS ATTRIBUTION LICENSE
It is a condition of publication in Infect Chemother that the authors grant an exclusive license to the journal’s sponsoring society, the Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, Korean Society for AIDS, and Korean Society of Pediatric Infectious Diseases. They also follow the Creative Commons Attribution Non-Commercial License available from: http://creativ…
Source ↗Publisher website ·- Open access OPEN ACCESS POLICY
Infect Chemother is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI …
Source ↗Publisher website ·- Peer review EDITORIAL AND PEER REVIEW PROCESS
Peer Review Process Infect Chemother reviews all manuscripts received. A manuscript is previewed for its format and academic relevancy. If the manuscript does not fit the aims and scope of Infect Chemother or does not adhere to the Instructions to Authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by S…
Source ↗Publisher website ·- Plagiarism Redundant Publication and Plagiarism
Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source (s)”. Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant p…
Source ↗Publisher website ·- Preprints PREPRINT POLICY
A preprint can be defined as a version of a scholarly paper that precedes formal peer review and publication in a peer-reviewed scholarly journal. Preprinted manuscripts in medRxiv, bioRixv or similar platforms are allowed to submit is allowed to Infect Chemother under provisions. Infect Chemother recommend authors to disclose it with DOI in the title page during the submission process. Otherwise,…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Jin Publishing & Printing Co.
- Country or region
- Korea, Republic of
- Language
- English
- ISSN
- 2093-2340
- Electronic ISSN
- 2092-6448
- Latest issue on the website
- Volume 58, Issue 2 (June 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Infection and Chemotherapy
What CAS zone is Infection and Chemotherapy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Infection and Chemotherapy is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Infection and Chemotherapy?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 65 days (interquartile range 32–85 days); authors report an average review time of about 22 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Infection and Chemotherapy?
According to the journal's author guidelines: Abstract: ≤ 400 words; Keywords: ≤ 5; Manuscript length: ≤ 5,500 words; Reference style: Vancouver; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Infection and Chemotherapy based?
Of the 55 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are South Korea (34), United States (6) and Japan (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Infection and Chemotherapy?
According to LetPub and DOAJ records, Infection and Chemotherapy is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PMC, PubMed, Embase and CAS; that list has not been checked against each database.
Is Infection and Chemotherapy open access, and what is the APC?
Infection and Chemotherapy is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .